We are monitoring the impact of COVID-19 on APAC Left Atrial Appendage Closure (LAAC) Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 460
Share on
Share on

Asia-Pacific Left Atrial Appendage Closure (LAAC) Market Analysis - Product Pipeline Analysis, Market Share Analysis, Company Profiles, Competitive Landscape & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 460
Pages: 112

Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting the population, with an estimated prevalence of about 2% in the general population. While stroke is the common morbidity associated, especially in the elderly where one-third of strokes are attributed to atrial fibrillation.

In atrial fibrillation, the Left Atrial Appendage acts as a site of blood stasis that can significantly increase the risk of thrombogenesis and subsequent systemic embolization of a clot - commonly leading to ischemic strokes. According to studies, the risk of thrombus formation is nearly 15% in patients with non-valvular atrial fibrillation and the LAA as the site for clot formation has more than 90% chance in these cases. Further, with the surgical approach of excluding the left atrial appendage from the circulation is fraught with high rates of incomplete closure, leading to increased stroke risk, the demand for LAAC devices is on the rise.

Current evidence suggests that percutaneous occlusion of the left atrial appendage (LAA) is the most efficacious method in reducing the risk of thromboembolic complications associated with atrial fibrillation and is a rapidly growing discipline in the field of structural cardiac interventions. And also the percutaneous left atrial appendage occlusion devices offer a viable alternative to oral anticoagulants in patients who are deemed a high risk for bleeding or are otherwise ineligible to receive anticoagulation.

The Amplatzer devices have been used in LAA occlusion for more than a decade, starting with off label use of an atrial septal occluder device for LAA occlusion. This was followed by the introduction of a dedicated Amplatzer cardiac plug (ACP) 1 and second-generation Amulet device for LAA occlusion. Both these devices are widely used outside the United States, however, in the US only the WATCHMAN device has been FDA approved. However, some additional key questions remain unanswered before these devices gain widespread commercial use. These include training requirements, regulatory framework, the role of learning curve and most prominently the selection of patient partners who are most likely to benefit from these devices.

Right now, the LAA closure devices market is occupied by only a few market players namely, Boston Scientific, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical and Sentreheart leaving the market with limited competition and the bundle of opportunities.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Marketed Product Analyses                  

                5.1 Market value             

                5.2 Forecasting (2016-2021)        

6. Pipeline Product analysis                        

                6.1 Overview    

                6.2 Pipeline Development Landscape    

                6.3 Clinical Trials               

                                6.3.1 Clinical Trial Size by Stage of Development

                                6.3.2 Clinical Trial Duration by Stage of Development


7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Boston Scientific       

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 AtriCure       

                8.3 St. Jude Medical       

                8.4 Lifetech Scientific (Shenzhen)            

                8.5 Coherex Medical      

                8.6 Sentreheart

9. Competitive Landscape                           

                9.1 Company share analysis        

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         


10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 


                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

APAC Left Atrial Appendage Closure (LAAC) Market

Please wait. . . . Your request is being processed


$ 1234 2950

Click for Request Sample